These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10720052)

  • 1. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients.
    Chung YS; Lee MD; Lee SK; Kim HM; Fitzpatrick LA
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1137-42. PubMed ID: 10720052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitors prevent bone loss in patients with Type 2 diabetes mellitus.
    Nakashima A; Nakashima R; Ito T; Masaki T; Yorioka N
    Diabet Med; 2004 Sep; 21(9):1020-4. PubMed ID: 15317608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lovastatin effects on bone mineral density in postmenopausal women with type 2 diabetes mellitus.
    Safaei H; Janghorbani M; Aminorroaya A; Amini M
    Acta Diabetol; 2007 Jun; 44(2):76-82. PubMed ID: 17530471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of serum 25-hydroxyvitaminD level on decreased bone mineral density at femoral neck and total hip in Chinese type 2 diabetes.
    Guo L; Gao Z; Ge H
    PLoS One; 2017; 12(11):e0188894. PubMed ID: 29190676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis.
    Liu J; Zhu LP; Yang XL; Huang HL; Ye DQ
    Bone; 2013 May; 54(1):151-6. PubMed ID: 23388418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of simvastatin with aromasin in an ovariectomized rat model: effects on the skeletal system.
    Chen SH; Chou FF; Ko JY
    Chang Gung Med J; 2010; 33(5):509-14. PubMed ID: 20979701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia.
    Chuengsamarn S; Rattanamongkoulgul S; Suwanwalaikorn S; Wattanasirichaigoon S; Kaufman L
    Bone; 2010 Apr; 46(4):1011-5. PubMed ID: 20045497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
    Planas J; Trilla E; Raventós C; Cecchini L; Orsola A; Salvador C; Placer J; Encabo G; Morote J
    BJU Int; 2009 Dec; 104(11):1637-40. PubMed ID: 19549260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of bone status in patients with central diabetes insipidus.
    Pivonello R; Colao A; Di Somma C; Facciolli G; Klain M; Faggiano A; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2275-80. PubMed ID: 9661594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
    Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S
    Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy.
    Legroux-Gerot I; Vignau J; Collier F; Cortet B
    Calcif Tissue Int; 2008 Nov; 83(5):315-23. PubMed ID: 18836675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus.
    Bilezikian JP; Josse RG; Eastell R; Lewiecki EM; Miller CG; Wooddell M; Northcutt AR; Kravitz BG; Paul G; Cobitz AR; Nino AJ; Fitzpatrick LA
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1519-28. PubMed ID: 23450056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients.
    Miyake Y; Shouzu A; Nishikawa M; Yonemoto T; Shimizu H; Omoto S; Hayakawa T; Inada M
    Arzneimittelforschung; 1999 Apr; 49(4):324-9. PubMed ID: 10337451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors.
    Cho Y; Choe E; Lee YH; Seo JW; Choi Y; Yun Y; Wang HJ; Ahn CW; Cha BS; Lee HC; Kang ES
    Metabolism; 2015 Apr; 64(4):482-8. PubMed ID: 25312577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Schott AM; Cormier C; Hans D; Favier F; Hausherr E; Dargent-Molina P; Delmas PD; Ribot C; Sebert JL; Breart G; Meunier PJ
    Osteoporos Int; 1998; 8(3):247-54. PubMed ID: 9797909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lean mass and fat mass predict bone mineral density in middle-aged individuals with noninsulin-requiring type 2 diabetes mellitus.
    Moseley KF; Dobrosielski DA; Stewart KJ; De Beur SM; Sellmeyer DE
    Clin Endocrinol (Oxf); 2011 May; 74(5):565-71. PubMed ID: 21198741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Chikamori T; Sugimoto K; Hamada T; Kitaoka H; Furuno T; Seo H; Doi Y
    J Cardiol; 2000 Feb; 35(2):95-101. PubMed ID: 10713930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study.
    Ruppert K; Cauley J; Lian Y; Zgibor JC; Derby C; Solomon DH
    Osteoporos Int; 2018 Feb; 29(2):347-354. PubMed ID: 29075805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of osteoporosis among postmenopausal females with diabetes mellitus.
    Al-Maatouq MA; El-Desouki MI; Othman SA; Mattar EH; Babay ZA; Addar M
    Saudi Med J; 2004 Oct; 25(10):1423-7. PubMed ID: 15494815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.